FEDERATED HERMES, INC. - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 90 filers reported holding SPERO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$3,838
-45.5%
2,647
-45.5%
0.00%
Q1 2023$7,037
+3623.3%
4,853
+4352.3%
0.00%
Q4 2022$189
-95.3%
109
-94.4%
0.00%
Q3 2022$4,000
+100.0%
1,952
-24.3%
0.00%
Q2 2022$2,000
-98.6%
2,579
-72.8%
0.00%
Q1 2021$139,0009,4730.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,932,209$76,246,00015.85%
Atlas Venture Associates XI, LLC 1,376,968$26,700,0004.23%
Atlas Venture Associates IX, LLC 1,376,968$26,700,0004.23%
BVF INC/IL 2,243,278$43,497,0001.71%
AWM Investment Company, Inc. 372,755$7,228,0000.92%
Alphabet Inc. 889,979$17,257,0000.83%
Rock Springs Capital Management LP 1,235,000$23,947,0000.51%
Novo Holdings A/S 576,702$11,182,0000.48%
Artal Group S.A. 500,000$9,695,0000.21%
Granahan Investment Management 420,320$8,150,0000.18%
View complete list of SPERO THERAPEUTICS INC shareholders